NMS·Healthcare·$2.2B·#229 / 520 in Healthcare
SGRY Surgery Partners, Inc.
48SPECULATIVE
CATEGORY BREAKDOWN
GROWTH10
QUALITY39
STABILITY67
VALUATION100
GOVERNANCE39
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+6.2%
10
> 50% strong
Gross Margin
Revenue retained after direct costs
23.1%
31
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
235.0%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
0.7x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
20
51
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
1.8%
14
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+2.0%
88
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE SGRY WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when SGRY's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.